Skip to main content
. 2011 Feb 8;11:31. doi: 10.1186/1471-2180-11-31

Table 6.

Primers used in this study

Primer Sequencea Directionb
P1 tatttctagatttcagtgcaat F
P2 ttaggtaccgcgaacgccagcaagacg R
P3 taaggtaccccggaattgccagctggg F
P4 ttaggatcctccgcgcacatttccccg R
P5 taacccgggaattctcatgtttgac F
P6 ttaagatctccatgccggcgataat R
P7 tgcttcaacagtacgaattcactatccggttcaataccaagttgcatgacgcatgcctgcagggcgcg F
P8 gttttgctgaatggcggcttcgttttgcccgccccaccatcacctgatgattatttgttaactgttaattgtc R
P9 ggcaacaatttctacaaaacacttgatactgtatgagcatacagtataattgcttcaacagtacgaa F
P10 gagaaatgccaaaagggccgcataaatgcagcccttgatggtaatttaacgttttgctgaatggcggc R
P11 taaactagtacgacagcagagtcctgtaccg F
P12 ttaggtacctgaagcttgtcatgcaacttggtattgaac R
P13 taaggtaccggatcctcatcaggtgatggtggggcgg F
P14 ttatctagatttgcgaacggcctgttcacgt R
P15 gatagcacgtgctatcttgtgc F
P16 tcgtcgcagacgctgttcgccg R
P17 ctagtctagacgtcagtgagaatcagctcaaa F
P18 caaggtaccatattagtacattcgtccagg R
P19 cgcggtaccagcgctgaacacgttatagacat F
P20 acatgcatgcgaatagtcacgacgatatcttt R
P21 ctagtctagacgtcagtgagaatcagctcaaaatc F
P22 cggggtaccatcaactcataaccagggcgttatc R
P23 cgactttatctttacctcgaagctggtggat F
P24 gttacggacacggagttatcggcgtgaata R
P25 ctagtctagaagattataacgcgctggg F
P26 cggggtaccgcgtattatttaccactggtc R
P27 cgcggtacctaatcggggcgatttaacaac F
P28 acatgcatgccttcgagcgatgaacgctct R
P29 gtctataaagcgccggatgagaaacatgtc F
P30 tcgacgatcgcttcgagcgatgaacgctct R
P31 taaaagcttgaccgcgactgtctgatcgt F
P32 tcaagatctctcgggcgcggagttgcccggc R
P33 taaagatcttgactgcagtgaaaaagcagtttgccacgat F
P34 ttagagctcagaaaggaataccggcatgaca R
P35 taaagatctcgatataagttgtaattctc F
P36 ttactgcaggcgaggtgccgccggcttcc R
P37 ttactgcagtccgcgcacatttccccg R
P38 ggggtaatgtcgtggaccatttgc F
P39 ccgcggtaatccccggcactaccg R
P40 gcgctacaaaccctgtggcaacaat F
P41 gctgtgatcgcggacagcaagaatac R
P42 ttctcaacataaaaaagtttgtgtaatactgaggatgcggcgtcacag F
P43 gttacggacacggagttatcggcgtgaata R

a The underlined sequences are enzyme sites mentioned in the text.

b Forward (F) or reverse (R) primers.

HHS Vulnerability Disclosure